|
df
|
Ride distance [km]
|
Ride duration [d]
|
Daily distance [km/d]
|
Sex (f = 1, m = 2)
|
BMI [kg/m2]
|
Electrolyte intake (no = 0, yes = 1)
|
Fluid intake [L/d]
|
Drinking strategy
|
Analgesic intake (no = 0, yes = 1)
|
---|
ambient
|
much
|
thirst
|
---|
Swelling symptoms (overall)
|
591
|
1.24
|
−.96
|
−.40
|
−5.26***
|
−.20
|
−.43
|
.49
|
−.55
|
2.11*
|
−.31
|
4.28***
|
Women
|
75
|
.72
|
−.20
|
.43
| |
.93
|
1.12
|
−.53
|
−.85
|
−.77
|
−.05
|
1.20
|
Men
|
504
|
1.11
|
−.99
|
−.51
| |
−.50
|
−.76
|
.64
|
.01
|
2.61**
|
−.32
|
3.72***
|
Facial swelling
|
593
|
.22
|
.44
|
.82
|
−3.91***
|
−.91
|
.37
|
.51
|
−.08
|
.73
|
−1.21
|
2.06***
|
Women
|
75
|
.94
|
−.43
|
−.00
| |
.62
|
1.87(*)
|
.36
|
−.71
|
−.53
|
.11
|
.61
|
Men
|
506
|
−.14
|
.67
|
.93
| |
−.88
|
−.29
|
.20
|
.29
|
.83
|
−1.45
|
1.60
|
Eyelid swelling
|
593
|
1.12
|
−.59
|
.14
|
−3.67***
|
−.61
|
.39
|
−.41
|
.15
|
1.17
|
−1.69(*)
|
2.08*
|
Women
|
75
|
1.06
|
−.56
|
−.12
| |
−.44
|
.99
|
−.36
|
−.21
|
−.83
|
−.14
|
1.09
|
Men
|
506
|
.80
|
−.41
|
.23
| |
−.33
|
−.04
|
−.44
|
.34
|
1.46
|
−1.80(*)
|
1.50
|
Swelling of fingers/hands
|
593
|
−.14
|
.06
|
.01
|
−2.86**
|
2.04*
|
−.44
|
.52
|
−.63
|
1.79(*)
|
−1.37
|
2.31*
|
Drinking strategy*BMI
|
590
|
−.04
|
.00
|
−.01
|
−2.90**
|
.26
|
−.45
|
.63
|
1.35
|
−.05
|
−1.36
|
2.25*
|
Women
|
72
|
.28
|
.26
|
−.32
| |
.00
|
.52
|
.05
|
.24
|
−.44
|
−.18
|
.01
|
Men
|
503
|
.04
|
−.20
|
.04
| |
−.08
|
−.45
|
.63
|
1.33
|
−.05
|
−2.03*
|
2.07*
|
Swelling of toes/feet
|
593
|
.54
|
−.32
|
−.02
|
−1.23
|
1.10
|
.72
|
−.09
|
−.57
|
1.02
|
−1.74
|
3.72***
|
Swelling of extremities (arms/legs)
|
593
|
.72
|
−.56
|
−.63
|
−2.55*
|
−.33
|
.12
|
.85
|
−.92
|
.38
|
−2.03*
|
2.26*
|
Women
|
75
|
.90
|
−.78
|
.76
| |
1.54
|
−.03
|
−1.03
|
.41
|
−.43
|
−.80
|
.65
|
Men
|
506
|
.06
|
.07
|
−.52
| |
−1.04
|
.53
|
1.23
|
−1.02
|
.65
|
−1.79(*)
|
2.14*
|
Reduced urine output
|
593
|
−.64
|
−.04
|
.13
|
−1.32
|
.03
|
1.37
|
.63
|
.31
|
1.63
|
−.08
|
.99
|
Increased urine output
|
593
|
.60
|
−.01
|
.09
|
−.79
|
−.48
|
1.98*
|
.31
|
−1.3
|
−1.23
|
−2.85**
|
1.02
|
Concentrated/darker urine
|
593
|
.33
|
−.71
|
−.42
|
.32
|
1.08
|
2.41*
|
−.58
|
−2.00*
|
.71
|
.59
|
.70
|
Less concentrated/lighter urine
|
593
|
−.23
|
.44
|
.63
|
−.76
|
.44
|
2.25*
|
1.04
|
−.54
|
.02
|
−2.43*
|
.91
|
Bubbly/foamy urine
|
593
|
.86
|
−.64
|
−.39
| |
.40
|
.88
|
.06
|
−.76
|
−.14
|
−1.39
|
.94
|
- Indented: specification of model, first column: dependent variable, second column: degrees of freedom, third column: predictors. Levels of significance: (*): marginal significance p < .10, *: p < 0.05, **: p < 0.01, ***: p < 0.001. Abbreviations: body mass index (BMI)